Hosted on MSN
GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B
British pharmaceutical company GSK (NYSE:GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 billion in cash. Under the agreement, GSK will pay $1.2 billion ...
The single-Stromberg Princess II arrived in 1950, while the Princess III, with a restyled front grille, followed in 1953. The most radical development was the 100mph Austin Princess IV (or DS7) which ...
Get breaking news and incisive analysis sent to your inbox. Choose from a number of free newsletter options at MarketWatch, including Need to Know, which provides a guide to the trading day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results